1887

n Cardiovascular Journal of South Africa - New agent ivabradine (Procoralan) for treatment of chronic stable angina : drug trends

USD

 

Abstract

Introduced at the European Society of Cardiology in September 2005 as an interesting and exciting new approach to the medical treatment of angina, Prof. Kim Fox of the Royal Brompton Hospital, London, welcomed the advent of ivabradine, the first new molecule since the introduction of calcium channel blockers (CCB) in the 1970s for the treatment of angina.

Loading

Article metrics loading...

/content/cardio/16/5/EJC24034
2005-09-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error